Point72 Middle East Fze Abbott Laboratories Call Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $1.02 Million - $1.25 Million	-11,300 Reduced 21.2%	42,000 $4.62 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $3.02 Million - $3.62 Million	31,600 Added 145.62%	53,300 $5.16 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $2.62 Million - $2.92 Million	-26,000 Reduced 54.51%	21,700 $2.37 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $3.39 Million - $3.99 Million	35,000 Added 275.59%	47,700 $4.83 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.21 Million - $1.42 Million	12,700 New	12,700 $0

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.